1. The Neurontin legacy — Marketing through misinformation and manipulation - Abstract

    2. Reporting biases of Neurontin - 2008 report by Dr K Dickersin (Cochrane Centre) - Paper

    3. Harms were detected but not reported in six clinical trials of gabapentin - Abstract

    4. Gabapentin doesn't improve pain control after amputation - Abstract

    5. Gabapentin doesn't improve pain control after TPLO - Abstract

    6. A high-quality meta-analysis does not support the routine use of pregabalin or gabapentin for the management of postoperative pain - Abstract

    7. Gabapentin prescribing trends in the UK - Paper

    8. 97% of US gabapentin prescriptions were off label between 2003 and 2016 - Abstract

    9. Prescribing practices for gabapentin as a painkiller among veterinary professionals - Abstract

    10. Gabapentin’s effectiveness as a surgical pain reliever evaporates when compared to a sedative - Abstract

    11. A high-quality meta-analysis including 859 patients concludes that gabapentinoids are ineffective for treatment of low back pain and radicular pain - Abstract

    12. Gabapentinoids have a significant risk of adverse effects without any demonstrated benefit for people with chronic lower back pain - Abstract

    13. A 2017 Cochrane Review concludes that ver half of those treated with gabapentin will not have worthwhile pain relief but may experience adverse events - Abstract

    14. Overview of off-label gabapentinoid use - Abstract

    15. 15-min JAMA interview with two pain specialists about gabapentin overprescribing - Audio

    16. Lack of effectiveness of tramadol for canine arthritis - Abstract

    17. National Institute for Health and Care Excellence (NICE) guidelines for osteoarthritis - Web Page

    18. People taking gabapentinoids “felt like zombies” - Abstract

    19. Gabapentin produces an average 2.2kg weight gain within 6 weeks - Abstract

    20. Retrospective study of 240 dogs receiving gabapentin for chronic pain relief - Abstract

    21. Gabapentin and gabapentin-meloxicam were not better than placebo in 29 dogs with neuropathic pain - Abstract

    22. Hypothyroidism induced by phenytoin and gabapentin - Abstract

    23. Gabapentinoid pharmacology in the context of emerging misuse liability - Abstract

    24. 7/10 dog owners reported that gabapentin helped with behavioural problems, while 7/10 reported at least one side-effect - Abstract

    25. The incidence of delirium with gabapentinoids is significantly higher in elderly patients - Abstract

    26. A small minority of people with hip or knee arthritis have neuropathic pain - Abstract

    27. Falls were significantly more likely in people with impaired kidney function taking gabapentinoids - Abstract

Next

LIBRELA